Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 87 (4) , 349-363
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive PathogensClinical Infectious Diseases, 2011
- Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-AnalysisAntimicrobial Agents and Chemotherapy, 2009
- The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelasInternational Journal Of Clinical Practice, 2009
- Daptomycin Pharmacokinetics in Adult Oncology Patients with Neutropenic FeverAntimicrobial Agents and Chemotherapy, 2009
- Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolatesJournal of Antimicrobial Chemotherapy, 2008
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of NephrotoxicityAntimicrobial Agents and Chemotherapy, 2008
- Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive BacteriaAntimicrobial Agents and Chemotherapy, 2008
- Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure InfectionsAntimicrobial Agents and Chemotherapy, 2007
- Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patientsJournal of Infection, 2007
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986